Quest Diagnostics, Inc. (DGX) Tops Q4 EPS Views; Guides FY12 EPS Below Views
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $195.00 -1.4%
EPS Growth %: +7.6%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +7.6%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $1.19, 13 cents better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.86 billion.
Quest Diagnostics, Inc. sees FY2012 EPS of $4.40-$4.55, versus the consensus of $4.66.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Quest Diagnostics, Inc. sees FY2012 EPS of $4.40-$4.55, versus the consensus of $4.66.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
